CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients von Pockros, Paul J., Fuchs, Michael, Freilich, Bradley, Schiff, Eugene, Kohli, Anita, Lawitz, Eric J., Hellstern, Paul A., Owens‐Grillo, Janet, Van Biene, Courtney, Shringarpure, Reshma, MacConell, Leigh, Shapiro, David, Cohen, David E.

Volltext

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and trea... von Lawitz, Eric, Prof, Sulkowski, Mark S, Prof, Ghalib, Reem, MD, Rodriguez-Torres, Maribel, MD, Younossi, Zobair M, Prof, Corregidor, Ana, MD, DeJesus, Edwin, MD, Pearlman, Brian, Prof, Rabinovitz, Mordechai, Prof, Gitlin, Norman, MD, Lim, Joseph K, MD, Pockros, Paul J, MD, Scott, John D, MD, Fevery, Bart, MSc, Lambrecht, Tom, MSc, Ouwerkerk-Mahadevan, Sivi, PhD, Callewaert, Katleen, MSc, Symonds, William T, PharmD, Picchio, Gaston, PhD, Lindsay, Karen L, MD, Beumont, Maria, MD, Jacobson, Ira M, Prof

Volltext

Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C von Pan, Jason J., Bao, Fei, Du, Emma, Skillin, Chase, Frenette, Catherine T., Waalen, Jill, Alaparthi, Lakshmi, Goodman, Zachary D., Pockros, Paul J.

Volltext

Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies von Pockros, Paul J, Guyader, Dominque, Patton, Heather, Tong, Myron J, Wright, Terry, McHutchison, John G, Meng, Tze-Chiang

Volltext

Impact of obesity on treatment of chronic hepatitis C von Charlton, Michael R., Pockros, Paul J., Harrison, Stephen A.

Volltext

JUMP‐C: A randomized trial of mericitabine plus pegylated interferon alpha‐2a/ribavirin for 24 weeks in treatment‐naïve HCV genotype 1/4 patients von Pockros, Paul J., Jensen, Donald, Tsai, Naoky, Taylor, Ryan, Ramji, Alnoor, Cooper, Curtis, Dickson, Rolland, Tice, Alan, Kulkarni, Rohit, Vierling, John M., Lou Munson, Marie, Chen, Ya‐Chi, Najera, Isabel, Thommes, James

Volltext

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients von Patton, Heather M, Patel, Keyur, Behling, Cynthia, Bylund, David, Blatt, Lawrence M, Vallée, Marc, Heaton, Shanon, Conrad, Andrew, Pockros, Paul J, McHutchison, John G

Volltext

Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols von DUCHINI, Andrea, GOSS, John A, KARPEN, Saul, POCKROS, Paul J

Volltext

Latent Autoimmune Diabetes in Adults (LADA) Occurring in a Patient with Primary Biliary Cholangitis von Lee, Byung K., Pak, Kevin, Pockros, Paul J.

Volltext

Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study von Eksteen, Bertus, Bowlus, Christopher L., Montano‐Loza, Aldo J., Lefebvre, Eric, Fischer, Laurent, Vig, Pamela, Martins, Eduardo Bruno, Ahmad, Jawad, Yimam, Kidist K., Pockros, Paul J., Feld, Jordan J., Minuk, Gerald, Levy, Cynthia

Volltext

New Direct-Acting Antiviral Therapies for Treatment of Chronic Hepatitis C Virus Infection von Ara, A Kardashian, Paul, J Pockros

Volltext

Novel emerging treatments for hepatitis C infection: a fast-moving pipeline von Kardashian, Ara A., Pockros, Paul J.

Volltext

Advances in newly developing therapy for chronic hepatitis C virus infection von Pockros, Paul J.

Volltext

Effect of peginterferon alfa‐2a on liver histology in chronic hepatitis C: A meta‐analysis of individual patient data von Cammà, Calogero, Di Bona, Danilo, Schepis, Filippo, Heathcote, E. Jenny, Zeuzem, Stefan, Pockros, Paul J., Marcellin, Patrick, Balart, Luis, Alberti, Alfredo, Craxì, Antonio

Volltext

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease von Pockros, Paul J, Reddy, K. Rajender, Mantry, Parvez S, Cohen, Eric, Bennett, Michael, Sulkowski, Mark S, Bernstein, David E, Cohen, Daniel E, Shulman, Nancy S, Wang, Deli, Khatri, Amit, Abunimeh, Manal, Podsadecki, Thomas, Lawitz, Eric

Volltext

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study von Nelson, David R., Cooper, James N., Lalezari, Jacob P., Lawitz, Eric, Pockros, Paul J., Gitlin, Norman, Freilich, Bradley F., Younes, Ziad H., Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J., Ortiz‐Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M., Varunok, Peter, Kowdley, Kris V., Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A.

Volltext

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection von Afdhal, Nezam, Reddy, K. Rajender, Nelson, David R, Lawitz, Eric, Gordon, Stuart C, Schiff, Eugene, Nahass, Ronald, Ghalib, Reem, Gitlin, Norman, Herring, Robert, Lalezari, Jacob, Younes, Ziad H, Pockros, Paul J, Di Bisceglie, Adrian M, Arora, Sanjeev, Subramanian, G. Mani, Zhu, Yanni, Dvory-Sobol, Hadas, Yang, Jenny C, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Sulkowski, Mark, Kwo, Paul

Volltext

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis von Kowdley, Kris V, Gordon, Stuart C, Reddy, K. Rajender, Rossaro, Lorenzo, Bernstein, David E, Lawitz, Eric, Shiffman, Mitchell L, Schiff, Eugene, Ghalib, Reem, Ryan, Michael, Rustgi, Vinod, Chojkier, Mario, Herring, Robert, Di Bisceglie, Adrian M, Pockros, Paul J, Subramanian, G. Mani, An, Di, Svarovskaia, Evguenia, Hyland, Robert H, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Pound, David, Fried, Michael W

Volltext

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response von Terrault, Norah A, Zeuzem, Stefan, Di Bisceglie, Adrian M, Lim, Joseph K, Pockros, Paul J, Frazier, Lynn M, Kuo, Alexander, Lok, Anna S, Shiffman, Mitchell L, Ben Ari, Ziv, Akushevich, Lucy, Vainorius, Monika, Sulkowski, Mark S, Fried, Michael W, Nelson, David R

Volltext

Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis von Bowlus, Christopher L., Pockros, Paul J., Kremer, Andreas E., Parés, Albert, Forman, Lisa M., Drenth, Joost P.H., Ryder, Stephen D., Terracciano, Luigi, Jin, Yuying, Liberman, Alexander, Pencek, Richard, Iloeje, Uche, MacConell, Leigh, Bedossa, Pierre

Volltext